However, the incapacity of XP-deficient cells to repair CPD lesions and recover the basal levels remains unaffected by the RhoA LoF (Figure 7), therefore sustaining the hypothesis of this work that RhoA GTPase mediates NER pathway function. The gene discussed is RHOA; the disease is xeroderma pigmentosum.